Association of Pre-Admission Statin Use With Reduced In-Hospital Mortality in COVID-19
- 2 March 2021
- journal article
- research article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 361 (6), 725-730
- https://doi.org/10.1016/j.amjms.2021.03.001
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study*Inflammatory Bowel Diseases, 2012
- Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate StudyThe Journal of Infectious Diseases, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-AnalysisPLOS ONE, 2010
- Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort StudyPLOS ONE, 2009
- Influenza and COPD Mortality Protection as Pleiotropic, Dose-Dependent Effects of StatinsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases*Critical Care Medicine, 2007
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study)The American Journal of Cardiology, 1998